These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24662560)

  • 21. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab-induced T cell depletion in patients with rheumatoid arthritis: association with clinical response.
    Mélet J; Mulleman D; Goupille P; Ribourtout B; Watier H; Thibault G
    Arthritis Rheum; 2013 Nov; 65(11):2783-90. PubMed ID: 23918413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.
    Breedveld F; Agarwal S; Yin M; Ren S; Li NF; Shaw TM; Davies BE
    J Clin Pharmacol; 2007 Sep; 47(9):1119-28. PubMed ID: 17766699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry).
    Glace B; Gottenberg JE; Mariette X; Philippe R; Pereira B; Lequerré T; Berthelot JM; Dougados M; Toussirot E; Pham T; Allanore Y; Loeuille D; Euller-Ziegler L; Soubrier M
    Ann Rheum Dis; 2012 Aug; 71(8):1429-31. PubMed ID: 22504557
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis.
    Vallet H; Houitte R; Azria A; Mariette X
    J Rheumatol; 2011 May; 38(5):965-6. PubMed ID: 21532065
    [No Abstract]   [Full Text] [Related]  

  • 26. The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis.
    Brinkman IH; van de Laar MA; Jansen TL; van Roon EN
    Expert Opin Drug Saf; 2011 Sep; 10(5):715-26. PubMed ID: 21401437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytomegalovirus meningoencephalitis after rituximab treatment for primary central nervous system lymphoma.
    Siakantaris MP; Argyropoulos KV; Ioannou S; Papadopoulou V; Tzeletas G; Tsonis J; Dimitrakopoulou A; Yiannopoulou KG; Pangalis GA; Vaiopoulos G
    Neurologist; 2015 Jan; 19(2):35-7. PubMed ID: 25607329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U; Tzadok S; Amir S; Mandelboim M; Mendelson E; Wigler I; Sarbagil-Maman H; Paran D; Caspi D; Elkayam O
    Vaccine; 2011 Feb; 29(8):1643-8. PubMed ID: 21211590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.
    Gottenberg JE; Cinquetti G; Larroche C; Combe B; Hachulla E; Meyer O; Pertuiset E; Kaplanski G; Chiche L; Berthelot JM; Gombert B; Goupille P; Marcelli C; Feuillet S; Leone J; Sibilia J; Zarnitsky C; Carli P; Rist S; Gaudin P; Salliot C; Piperno M; Deplas A; Breban M; Lequerre T; Richette P; Ghiringhelli C; Hamidou M; Ravaud P; Mariette X;
    Ann Rheum Dis; 2013 Jun; 72(6):1026-31. PubMed ID: 23264337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease.
    Hoffman Snyder C; Mishark KJ; Caviness JN; Drazkowski JF; Caselli RJ
    Arch Neurol; 2006 May; 63(5):766-8. PubMed ID: 16682549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
    Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
    J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
    Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Taoufik Y
    Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rationale and clinical evidence for the use of rituximab in glomerular diseases].
    Mani LY; Vogt B; Burnier M; Golshayan D
    Rev Med Suisse; 2011 Apr; 7(290):819-24. PubMed ID: 21595313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center.
    Besada E; Koldingsnes W; Nossent J
    QJM; 2012 Jun; 105(6):545-50. PubMed ID: 22301823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al.
    Bredemeier M
    Ann Rheum Dis; 2014 Jun; 73(6):e33. PubMed ID: 24595549
    [No Abstract]   [Full Text] [Related]  

  • 36. [Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome].
    Imai E
    Nihon Jinzo Gakkai Shi; 2012; 54(5):593-7. PubMed ID: 22991838
    [No Abstract]   [Full Text] [Related]  

  • 37. Off-label use of rituximab in systemic rheumatic diseases: case series and review.
    Araújo F; Silva I; Sepriano A; Nero P; Branco JC
    Acta Reumatol Port; 2013; 38(4):290-4. PubMed ID: 24435034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical psoriasis following rituximab for rheumatoid arthritis.
    Hardcastle SA; Gibbs S; Williamson L
    J Rheumatol; 2012 Jun; 39(6):1303-4. PubMed ID: 22661424
    [No Abstract]   [Full Text] [Related]  

  • 39. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?
    Lis-Święty A; Brzezińska-Wcisło L; Widuchowska M; Kucharz E
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):443-6. PubMed ID: 23537059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.
    Vos K; Thurlings RM; Wijbrandts CA; van Schaardenburg D; Gerlag DM; Tak PP
    Arthritis Rheum; 2007 Mar; 56(3):772-8. PubMed ID: 17328049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.